Dyne therapeutics news
WebJan 19, 2024 · Dyne Therapeutics, Inc. (NASDAQ: DYN) is a Waltham, Massachusetts based early clinical-stage biopharmaceutical concern focused on the development of oligonucleotide (small bits of RNA or DNA ... WebMay 16, 2024 · DYNE-101 is designed to enable targeted delivery to muscle tissue and address the genetic basis of the disease. The new data being presented during ASGCT evaluated monthly repeat doses of DYNE-101 ...
Dyne therapeutics news
Did you know?
WebOct 31, 2024 · WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for ... WebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24.
WebDyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like ... WebApr 4, 2024 · Dyne Therapeutics Stock Performance. Shares of DYN stock opened at $11.05 on Tuesday. The firm’s 50-day moving average is $13.08 and its 200-day moving average is $12.22. The stock has a market ...
WebMar 23, 2024 · WALTHAM, Mass., March 23, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on … WebGet the latest Dyne Therapeutics Inc (DYN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …
WebApr 11, 2024 · Dyne Therapeutics Trading Down 6.0 %. DYN stock opened at $8.82 on Tuesday. The firm has a 50 day moving average of $12.59 and a 200-day moving …
WebMar 2, 2024 · - Data Anticipated in the Second Half of 2024 from ACHIEVE Clinical Trial of DYNE-101 in DM1 and DELIVER Clinical Trial of DYNE-251 in DMD - WALTHAM, Mass., March 02, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life … highest jump in nbaWebOct 31, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to … how good are horizon hearing aidsWebMar 20, 2024 · Dyne links therapeutic payloads to its TfR1-binding fragment antibody (Fab) to develop targeted therapeutics for muscle diseases. About DYNE-101 and the ACHIEVE Trial. DYNE-101 is an investigational therapeutic being evaluated in the Phase 1/2 global ACHIEVE trial, for people living with myotonic dystrophy type 1 (DM1). how good are greenmaster bowlsWebApr 11, 2024 · On average, analysts predict that Dyne Therapeutics will post -3.23 EPS for the current year. Insider Activity at Dyne Therapeutics. In related news, insider Jonathan Mcneill sold 10,000 shares of the company's stock in a transaction dated Wednesday, January 18th. The shares were sold at an average price of $14.03, for a total value of … how good are hp computersWebGet the latest Dyne Therapeutics, Inc. (DYN) stock news and headlines to help you in your trading and investing decisions. how good are hearing aids bought onlineWebApr 11, 2024 · Let’s start up with the current stock price of Dyne Therapeutics Inc. (DYN), which is $8.82 to be very precise. The Stock rose vividly during the last session to $9.35 after opening rate of $9.34 while the lowest price it went was recorded $8.77 before closing at $9.38.Recently in News on March 23, 2024, Dyne Therapeutics Receives FDA … how good are harley benton guitarsWebApr 3, 2024 · To solve that problem, a startup called Dyne Therapeutics has raised $50 million in series A financing to develop antibody-oligo conjugates that shuttle oligo therapies into muscle cells. The idea ... highest jump in nba history